Literature DB >> 25192224

Vitrification versus slow freezing for women undergoing oocyte cryopreservation.

Demián Glujovsky1, Barbara Riestra, Carlos Sueldo, Gabriel Fiszbajn, Sjoerd Repping, Florencia Nodar, Sergio Papier, Agustín Ciapponi.   

Abstract

BACKGROUND: Oocyte cryopreservation is a technique with considerable potential in reproductive medicine, including  fertility preservation, as a way of delaying childbearing and as part of oocyte donation programs. Although the technique was relatively ineffective at first more recently numerous modifications have led to higher success rates.
OBJECTIVES: To compare the effectiveness and safety of vitrification and slow freezing as oocyte cryopreservation techniques for fertility outcomes in women undergoing assisted reproduction. SEARCH
METHODS: We searched electronic databases, trial registers and websites, including the Cochrane Menstrual Disorders and Subfertility Group Specialised Register of controlled trials, Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE and PsycINFO (date of search 3 March 2014). SELECTION CRITERIA: Two review authors independently selected randomised controlled trials (RCTs) comparing vitrification and slow freezing for oocyte preservation in women undergoing assisted reproduction. DATA COLLECTION AND ANALYSIS: Two review authors independently extracted the data from eligible studies and assessed their risk of bias. Any disagreements were resolved by discussion or by a third review author. Data extracted included study characteristics and outcome data. The overall quality of the evidence was assessed using GRADE methods. MAIN
RESULTS: Two RCTs were included in the review (106 participants). Neither study reported live birth rate. Vitrification was associated with an increased clinical pregnancy rate compared to slow freezing (RR 3.86, 95% CI 1.63 to 9.11, P = 0.002, 2 RCTs, 106 women, I(2) = 8%, moderate quality evidence). The effect of vitrification compared to slow freezing on ongoing pregnancy rates was only reported in one small study, with inconclusive findings (RR 6.07, 95% CI 0.86 to 43.04, P = 0.07, one RCT, 28 women, low quality evidence).No data were reported on adverse effects, nor were any other outcomes reported in the included trials. The evidence was limited by imprecision. We assessed the included studies as at low to unclear risk of bias as the methods were not well described. AUTHORS'
CONCLUSIONS: Oocyte vitrification compared to slow freezing probably increases clinical pregnancy rates in women undergoing assisted reproduction. However, the total number of women and pregnancies were low and the imprecision is high which limits applicability. The effect on ongoing pregnancy is uncertain as data were sparse. No data were available on live births or adverse effects.

Entities:  

Mesh:

Year:  2014        PMID: 25192224     DOI: 10.1002/14651858.CD010047.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  16 in total

Review 1.  Fertility preservation options in transgender people: A review.

Authors:  Natnita Mattawanon; Jessica B Spencer; David A Schirmer; Vin Tangpricha
Journal:  Rev Endocr Metab Disord       Date:  2018-09       Impact factor: 6.514

2.  Assisted reproductive technology: an overview of Cochrane Reviews.

Authors:  Cindy Farquhar; Jane Marjoribanks
Journal:  Cochrane Database Syst Rev       Date:  2018-08-17

3.  Freeze/thaw stress induces organelle remodeling and membrane recycling in cryopreserved human mature oocytes.

Authors:  Stefania Annarita Nottola; Elena Albani; Giovanni Coticchio; Maria Grazia Palmerini; Caterina Lorenzo; Giulia Scaravelli; Andrea Borini; Paolo Emanuele Levi-Setti; Guido Macchiarelli
Journal:  J Assist Reprod Genet       Date:  2016-09-01       Impact factor: 3.412

4.  Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.

Authors:  Sara Crawford; Sheree L Boulet; Jennifer F Kawwass; Denise J Jamieson; Dmitry M Kissin
Journal:  Fertil Steril       Date:  2016-11-11       Impact factor: 7.329

Review 5.  Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews.

Authors:  Selma Mourad; Julie Brown; Cindy Farquhar
Journal:  Cochrane Database Syst Rev       Date:  2017-01-23

Review 6.  Advanced technologies for the preservation of mammalian biospecimens.

Authors:  Haishui Huang; Xiaoming He; Martin L Yarmush
Journal:  Nat Biomed Eng       Date:  2021-08-23       Impact factor: 29.234

7.  In-vitro maturation and cryopreservation of oocytes at the time of oophorectomy.

Authors:  Melanie L Walls; Kirsty Douglas; John P Ryan; Jason Tan; Roger Hart
Journal:  Gynecol Oncol Rep       Date:  2015-08-07

8.  Cancer and fertility preservation: international recommendations from an expert meeting.

Authors:  Matteo Lambertini; Lucia Del Mastro; Maria C Pescio; Claus Y Andersen; Hatem A Azim; Fedro A Peccatori; Mauro Costa; Alberto Revelli; Francesca Salvagno; Alessandra Gennari; Filippo M Ubaldi; Giovanni B La Sala; Cristofaro De Stefano; W Hamish Wallace; Ann H Partridge; Paola Anserini
Journal:  BMC Med       Date:  2016-01-04       Impact factor: 8.775

9.  Preservation of female fertility in humans and animal species.

Authors:  Helen Mary Picton
Journal:  Anim Reprod       Date:  2018-08-17       Impact factor: 1.807

10.  Who benefits from putting family life into ice?

Authors:  Outi Hovatta
Journal:  Ups J Med Sci       Date:  2016-10-19       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.